Home » New cases in Kazakhstan fall in a single day and those who violate quarantine measures will be punished

New cases in Kazakhstan fall in a single day and those who violate quarantine measures will be punished

by admin

 (Fighting New Coronary Pneumonia) New cases in Kazakhstan drop in a single day and those who violate quarantine measures will be punished

China News Service, Nur Sultan, June 8 (Reporter Zhang Shuo) The recent epidemic in Kazakhstan, a Central Asian country, has continued to slow down. As of the 8th local time, the number of new confirmed cases in the country in a single day has been below 1,000 for two days.

As of the 8th, Kazakhstan has accumulated more than 451,000 confirmed cases of new coronary pneumonia and pneumonia cases with symptoms of new coronary pneumonia but negative laboratory virus test results. In the past 24 hours, more than 770 newly diagnosed cases of the above-mentioned “two pneumonias” have been confirmed.

According to the Kazakh National Public Health Center, as of that day, Nur-Sultan and Karaganda are the “red areas” of the epidemic risk level, and Almaty, Atyrau, Akmola, Sikha and Pav Lodar State is the “yellow zone” of epidemic risk, and other areas are the “green zone”.

According to the Kazakhstan Health and Epidemiological Supervision Committee, according to the requirements of the Kazakhstan Ministry of Health‘s epidemic prevention regulations, from the 10th, patients with new coronary pneumonia and close contacts must strictly self-isolate, otherwise they will be subject to administrative penalties. The committee stated that if relevant personnel still violate the self-isolation system and intentionally cause the risk of infection to the health of others when they know they are infected, they will bear administrative responsibility and face a fine of 87,510 tenge (approximately RMB 1,310).

See also  The Taliban marries a girl, the UN Secretary-General is shocked and heartbroken (photo) | Taliban | Afghanistan |

In addition, Kiyasov, the Deputy Minister of Health of Kazakhstan and the country’s chief health physician, recently revised the resolution on “Strengthening Measures to Prevent the Import of New Coronary Pneumonia Cases from India”. According to the amendment, people who have stayed in India within 14 days starting from 0:00 on the 5th, regardless of whether they have a negative nucleic acid test certificate, must stay at home for 14 days after entering Kazakhstan. In addition, Kiyasov said that according to relevant resolutions, starting from 0:00 on the 5th, passengers arriving on international flights or arriving from border ports should provide a certificate of negative nucleic acid test within 3 days.

In addition, according to the head of SK Pharmaceutical Company Iskaliyev, when introducing the vaccine supply situation, the Ministry of Health of Kazakhstan has purchased vaccines through the national unified distributor SK Pharmaceutical Company and has ordered the Russian “Satellite V” vaccine 1028. Ten thousand doses, of which 1.9 million doses of the first dose of vaccine and 1.4 million doses of the second dose of vaccine have been shipped. As of the 1st of this month, 1.2 million first doses and 525,000 second doses of vaccines are being distributed. Iskaliyev said that 100,000 doses of the Kazakhstan-made “QazCovid-in” vaccine have been supplied to all regions, and the next batch will be supplied by the end of June.

According to data from the Ministry of Health of Kazakhstan, as of the 8th, about 2,285,898 people had completed the first dose of vaccination, and about 1213041 had completed the second dose of vaccination. (Finish)

See also  Jiemian Zaobao|Five confirmed cases of new coronary pneumonia have been confirmed in Ejina Banner, Inner Mongolia, and the National Medical Insurance Bureau sent a working group to Shandong to supervise insurance fraud incidents_公司

.

You may also like

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy